Find

Centre for Faecal Microbiota Transplantation - CEFTA

Publications

Sort by: Date | Author | Title

Hvas, C. L., Bendix, M., Dige, A., Dahlerup, J. F. & Agnholt, J. (2018). Current, experimental, and future treatments in inflammatory bowel disease: a clinical review. Immunopharmacology and Immunotoxicology, 40(6), 446-460. https://doi.org/10.1080/08923973.2018.1469144

Hvas, C. L., Ott, P., Paine, P., Lal, S., Jørgensen, S. P. & Dahlerup, J. F. (2018). Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature. World Journal of Gastroenterology, 24(21), 2320-2326. https://doi.org/10.3748/wjg.v24.i21.2320

Hvas, C. L., Jørgensen, S. M. D., Jørgensen, S. P., Storgaard, M., Lemming, L., Hansen, M. M., Erikstrup, C. & Dahlerup, J. F. (2019). Fecal Microbiota Transplantation is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection. Gastroenterology, 156(5), 1324-1332.e3. https://doi.org/10.1053/j.gastro.2018.12.019

Hvas, C. L., Baunwall, S. M. D. & Erikstrup, C. (2020). Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity. EClinicalMedicine, 24, Article 100436. https://doi.org/10.1016/j.eclinm.2020.100436

Hvas, C. L., Keller, J. J., Dahl Baunwall, S. M., Edwards, L. A., Ianiro, G., Kupcinskas, J., Link, A., Mullish, B. H., Satokari, R., Sokol, H., Terveer, E. M. & Vehreschild, M. JGT. (2023). European Academic Faecal Microbiota Transplantation (EurFMT) Network: improving the safety and quality of microbiome therapies in Europe. Microbiota in Health and Disease, 5, Article e954. https://doi.org/10.26355/mhd_202311_954

Hvas, C. L. (2007). Modulation of cellular immune responses by bacterial products. Implications for Crohn's disease.

Hansen, M. M., Rågård, N., Andreasen, P. W., Paaske, S. E., Dahlerup, J. F., Mikkelsen, S., Erikstrup, C., Baunwall, S. M. D. & Hvas, C. L. (2024). Encapsulated donor faeces for faecal microbiota transplantation: the Glyprotect protocol. Therapeutic Advances in Gastroenterology, 17, 17562848241289065. https://doi.org/10.1177/17562848241289065

Hammeken, L. H., Baunwall, S. M. D., Hvas, C. L. & Ehlers, L. H. (2021). Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review. Health Economics Review, 11(1), Article 3. https://doi.org/10.1186/s13561-021-00301-7

Hammeken, L. H., Baunwall, S. M. D., Dahlerup, J. F., Hvas, C. L. & Ehlers, L. H. (2022). Health-related quality of life in patients with recurrent Clostridioides difficile infections. Therapeutic Advances in Gastroenterology, 15. https://doi.org/10.1177/17562848221078441

Grosen, A. K., Povlsen, J., Lemming, L. E., Dahl Jørgensen, S. M., Dahlerup, J. F. & Hvas, C. L. (2019). Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae from a Renal Transplant Recipient with Recurrent Urinary Tract Infections. Case Reports in Nephrology and Dialysis, 9(2), 102-107. https://doi.org/10.1159/000502336

Dehlholm-Lambertsen, E., Hall, B. K., Jørgensen, S. M. D., Jørgensen, C. W., Jensen, M. E., Larsen, S., Jensen, J. S., Ehlers, L., Dahlerup, J. F. & Hvas, C. L. (2019). Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection. Therapeutic Advances in Gastroenterology, 12, Article 1756284819843002. https://doi.org/10.1177/1756284819843002

Dahl Jørgensen, S. M., Erikstrup, C., Dinh, K. M., Lemming, L. E., Dahlerup, J. F. & Hvas, C. L. (2018). Recruitment of feces donors among blood donors: Results from an observational cohort study. Gut Microbes, 9(6), 540-550. https://doi.org/10.1080/19490976.2018.1458179

Dahl Baunwall, S. M., Andreasen, S. E., Hansen, M. M., Kelsen, J., Høyer, K., Rågård, N., Eriksen, L. L., Støy, S., Rubak, T. M. M., Damsgaard, E. M. S., Mikkelsen, S., Erikstrup, C., Dahlerup, J. F. & Hvas, C. L. (2022). Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial. The Lancet Gastroenterology and Hepatology, 7(12), 1083-1091. https://doi.org/10.1016/S2468-1253(22)00276-X

Cold, F., Baunwall, S. M. D., Dahlerup, J. F., Petersen, A. M., Hvas, C. L. & Hansen, L. H. (2021). Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy. Therapeutic Advances in Gastroenterology, 14. https://doi.org/10.1177/17562848211041004

Birch, C. R., Paaske, S. E., Jensen, M. B., Baunwall, S. M. D., Ehlers, L. H. & Hvas, C. L. (2025). Cost-effectiveness of faecal microbiota transplantation compared with vancomycin monotherapy for early Clostridioides difficile infection: economic evaluation alongside a randomized controlled trial. Journal of Hospital Infection, 155(1), 145-149. https://doi.org/10.1016/j.jhin.2024.11.003

Baunwall, S. M. D., Lee, M. M., Eriksen, M. K., Mullish, B. H., Marchesi, J. R., Dahlerup, J. F. & Hvas, C. L. (2020). Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis. EClinicalMedicine, 29-30, Article 100642. https://doi.org/10.1016/j.eclinm.2020.100642

Baunwall, S. M. D., Dahlerup, J. F., Engberg, J. H., Erikstrup, C., Helms, M., Juel, M. A., Kjeldsen, J., Nielsen, H. L., Nilsson, A. C., Rode, A. A., Vinter-Jensen, L. & Hvas, C. L. (2021). Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT). Scandinavian Journal of Gastroenterology, 56(9), 1056-1077. https://doi.org/10.1080/00365521.2021.1922749

Baunwall, S. M. D., Terveer, E. M., Dahlerup, J. F., Erikstrup, C., Arkkila, P., Vehreschild, M. JGT., Ianiro, G., Gasbarrini, A., Sokol, H., Kump, P. K., Satokari, R., De Looze, D., Vermeire, S., Nakov, R., Brezina, J., Helms, M., Kjeldsen, J., Rode, A. A., Kousgaard, S. J. ... Hvas, C. L. (2021). The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey. The Lancet Regional Health - Europe, 9, Article 100181. https://doi.org/10.1016/j.lanepe.2021.100181

Baunwall, S. M. D., Hansen, M. M., Andreasen, S. E., Eriksen, M. K., Rågård, N., Kelsen, J., Grosen, A. K., Mikkelsen, S., Erikstrup, C., Dahlerup, J. F. & Hvas, C. L. (2023). Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study. Alimentary Pharmacology and Therapeutics, 58(5), 503-515. https://doi.org/10.1111/apt.17642

Bahl, M. I., Jørgensen, S. M. D., Skriver, A. H., Larsen, N. A., Wang, M., Licht, T. R., Dahlerup, J. F. & Hvas, C. L. (2020). Faecal microbiota transplantation for eradication of co-infection with Clostridioides difficile and extensively drug-resistant KPC-producing Klebsiella pneumoniae. Scandinavian Journal of Gastroenterology, 55(5), 626-630. https://doi.org/10.1080/00365521.2020.1753806

Displaying results 21 to 40 out of 41

2

Revised 11.09.2025

-

CEFTA web editor